Cell labeling with various types of nanomaterial, such as FDA-approved iron oxide nanoparticles (IONPs) has become common practice in biomedical research. The low uptake of IONPs stimulates the use of transfection agents (TA), but the effect on stability of the IONPs and their cellular interactions has received minimal attention. In the present study, we evaluated the use of Lipofectamine as a commonly used TA and tested different ratios of TA and IONPs. While the TA-IONP complexes are stable in saline, at a high ratio of TA over IONP, substantial aggregation occurred in serum-containing media. Even for the highest ratio, TA was unable to completely cover the IONPs, resulting in a net negative charge of all complexes. At high TA-IONP ratios, more complexes remained surface-associated without internalization, resulting in cell death, while at lower TA-IONP ratios, complexes were more avidly taken up through fluid-phase pinocytosis and clathrin-mediated endocytosis. At later time points, the endocytosed complexes accumulated within the lysosomes and affected the appearance of lysosomal structures. The data indicate that TAs should be used with care as, depending on the ratio of TA and IONP, the complexes may aggregate, inducing cell death and preventing internalization. 
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Introduction
In biomedical research, iron oxide nanoparticles (IONPs) have been widely applied in several fields, including targeted drug (1) or gene (2) delivery or magnetic hyperthermia (3), but foremost as magnetic resonance imaging (MRI) contrast agents (4) . A wide variety of IONPs are available, varying in size from a few nanometers to over 1 micrometer and having coating materials ranging from synthetic polymers, lipids or dextran to small molecules (5) (6) (7) (8) (9) . To date, dextran-coated iron oxide cores (Endorem in Europe, Feridex in the USA) have been most widely applied and have been used extensively in clinical settings for the detection of liver pathologies. As one of the sole FDA-approved iron oxide formulations for direct intravenous injection, these particles have also been employed more frequently in biomedical research as agents for the magnetic labeling of (stem) cells. In 2008, however, Feridex production for the US market by AMAG Pharmaceuticals Inc. was stopped, impeding further advancements in this field. The particles still remain popular, however, as several clinical trials have been set up, all outside of the USA, using Endorem-labeled stem cells to evaluate the homing of these cells by serial MR tracking after transplantation (10) . Furthermore, owing to its long-time use in biomedicine, many data regarding interactions with tissues and cells are available, making it an ideal research tool.
One of the key issues which is still a matter of debate is the possible influence of Endorem particles on the cellular wellbeing. Several groups have recently shown that high levels of Endorem can affect cell proliferation and cellular morphology (9, 11) , where intracellular degradation may induce reactive oxygen species (ROS) and affect stem cell functionality (12) (13) (14) (15) (16) ). An in-depth evaluation of the potential (cytotoxic) effects of IONPs on cultured cells is therefore of primordial importance in order to stimulate any further progress in this field.
Furthermore, the efficiency of combining Endorem and transfection agents (TAs) to promote cellular uptake is still questionable as several reports hint at an increased uptake (17) , whereas others describe only surface association and no cellular internalization (18). Such surfacebound particles have been described to potentially impair cell homeostasis (19) and are also more likely to be desorbed from the cells after transplantation in vivo, greatly impeding the accuracy of any noninvasive imaging methods. For efficient and accurate MRI cell tracking, it is therefore highly beneficial if the IONPs are cell-internalized, where high numbers of cell surface-associated IONPs will endanger any further uses of these cells in an in vivo setting. 4 A first step in clarifying the complex interactions between IONPs and cultured cells consists of evaluating the uptake mechanism and the intracellular localization of the particles.
Endorem particles as such are reported to be generally taken up by means of fluid phase pinocytosis, reaching quite low intracellular nanoparticles levels (7) . To increase cellular uptake, it has been suggested to complex Endorem with commercial transfection agents such as protamine, poly-L-lysine or Lipofectamine prior to cell labeling (17, 20) . The effect of the transfection agents on the stability of Endorem in physiological buffer and the resulting interactions with cultured cells has only rarely been addressed (21) . The present work therefore aims to investigate the effect of Lipofectamine as one of the most frequently used commercial cationic transfection agents. Furthermore, the interactions of these complexes with cervical cancer cells (HeLa) has been studied in terms of uptake mechanisms and internalization efficiency. The obtained results will allow evaluation og whether complexation of Lipofectamine with Endorem affects the stability of the complexes in dispersion and will provide insight into the precise intracellular localization and uptake efficiency of the particles.
This will render it feasible to evaluate whether the addition of Lipofectamine is beneficial or detrimental for efficient cell labeling strategies and will help to point out possible shortcomings and drawbacks associated with the addition of this transfection agent.
Results and discussion.
Effect of lipofectamine on size and surface charge of endorem complexes.
Endorem consists of several 4 nm-diameter iron oxide nanocores that are embedded in a neutral dextran matrix, leading to a rather high variation in the number of iron oxide cores per particle and in the total size of the particles typically from 60 to 150 nm (5). During preparation, small amounts of citric acid are used, which can lead to the presence of several carboxyl groups on the dextran shell and induce a slightly negative surface potential (22) . serum-containing media (23) . Typically, Endorem and Lipofectamine are mixed in phosphatebuffered saline (PBS) and allowed to form stable complexes for 1 h prior to further dilution in cell media and application to cultured cells (17) . Table 1 shows the hydrodynamic diameter as measured by dynamic light scattering of pure Endorem or after complexation with Lipofectamine at 3 different ratios (100 µg Fe ml -1 and 2.5, 5 or 10 µg ml -1 ; these ratios are kept constant throughout the work, so that, when lower Endorem quantitities are used later on in the work, the amount of Lipofectamine is reduced accordingly) as a function of time and the surface potential of the complexes after 30 min. The data show that, in agreement with the literature (5), Endorem particles are rather polydisperse in size, but appear to be quite stable in PBS. Addition of Lipofectamine moderately increases the size of the complexes, in correlation to the amount of Lipofectamine added. Additionally, the complexes appear to be formed rapidly as no clear differences in sizes can be seen throughout the entire time-span of the experiment. Interestingly, after 30min, the surface charge of the complexes is only slightly altered after addition of Lipofectamine as, in all conditions, a net negative surface charge ismaintained. This trend was observed in three independent batches of TA-IONP complexes, of which the average value is given in Table 1 . The relatively low value obtained for free Endorem of about -6mV may be explained by the fact that measurements were performed in serum-free but Ca 2+ -and Mg 2+ -containing PBS. The latter ions might electrostatically interact with the negative surface and hereby result in only a very small negative -potential. The standard deviation increases with higher amounts of Lipofectamine, which may indicate an increased variability in surface charges between individual complexes. Taken together, these data show that the addition of Lipofectamine cannot reverse the overall surface charge of the Endorem complexes. We hypothesize that a substantial part of the Endorem surfaces remains unbound, while the other part becomes partially or completely coated with Lipofectamine, leading to local positive charges, which is beneficial for promoting attachment to the cell surface (Scheme 1a, b).
Cell association of Endorem-Lipofectamine complexes.
In order to investigate the interactions of the Endorem-Lipofectamine complexes with cultured cells, HeLa cells were exposed to serum-containing cell media containing the different complexes at 100 µg Fe ml -1 for 8 h and then stained for iron by means of diaminobenzidine (DAB)-enhanced Prussian blue staining. The complexes were incubated at three different ratios of Endorem and Lipofectamine [100 µg Fe ml -1 and 10 (Endo H), 5
(Endo M) and 2.5 µl ml -1 (Endo L)]. Throughout this work, Lipofectamine concentrations were kept at maximally 10 µl ml -1 as from earlier studies and our own experience, significant cytotoxic effects are induced when using higher Lipofectamine amounts (17) . HeLa cells were either incubated at 37 °C to allow normal endocytosis to occur or at 4 °C to block all active endocytic transport pathways and therefore only allowing cellular attachment of the complexes. Incubation also occurred at 37 °C with HeLa cells expressing mutant dynamin, an important mediator in several endocytic processes to validate that the TA-IONP complexes are internalized by active endocytosis mechanism(s). processes are blocked at 4 °C, the positive staining probably indicate cell surface-associated complexes (probably aggregates) rather than internalized complexes. This is also suggested by the images at lower Lipofectamine concentrations ( Fig. 1 b, Compared with pure Endorem particles (Fig. 1e) , the addition of Lipofectamine clearly enhances cellular association of the complexes, for all TA-IONP ratios. Probably, the incomplete surface covering of the IONPs by the TA will lead to a high heterogeneity in local surface charges, increasing the affinity of charged serum proteins to the complex surface, leading to a so-called protein corona (25) . Furthermore, it has been found that the thickness of the adsorbed protein layer correlates with the size of the NPs (26) , hinting at a higher number of proteins binding on the complexes with higher Lipofectamine contents. As single charged proteins may bind differences complexes, these proteins may act as bridges and thereby induce further interaction of the complexes with one another through the bound proteins and lead to aggregation (Scheme 1c). The association of serum proteins will also influence the way the complexes areinteracting with the cells, as recently shown for silver and gold NPs of similar sizes (27) or differences in NP stability and cell-nanoparticle (NP) interactions, depending on the type of culture medium used (28) . The degree of aggregation clearly depends on the ratio of Lipofectamine over Endorem and seemed much less where the Lipofectamine amount was kept at 5 ml ml -1 or below. These findings (the influence of cell media type and Lipofectamine-Endorem ratios) might explain the ambiguity in published data where Endorem-transfection agent complexes were described as well internalized (17), led to high amounts of cell surface association and internalization (14, 22) , or solely led to surface attachment (18).
Quantitative uptake and cell-association levels.
In order to evaluate in more detail the effect of complex composition on the number of surface-associated complexes over internalized ones, the amount of cell-associated iron was quantified, as shown in Fig. 2 . In Fig. 2 Based on these results we decided to use only medium amounts of Lipofectamine for further experiments (2.5 µl ml -1 and 50 mg Fe ml -1 Endorem), since this allows substantial uptake to be achieved while avoiding excessive aggregation and sedimentation of large complexes, as was observed for the highest TA concentration (cf. Scheme 1a). In order to further elucidate the endocytic routes involved, we have applied a number of pharmacological inhibitors (29) .
Incubation of the cells with the complexes and treatment with the carefully selected concentrations of inhibitors did not affect cell viability as assessed by lactate dehydrogenase and mitochondrial metabolism assays after 4 and 24 h (data not shown). percentages of uptake and uptake inhibition. Performing these calculations, it was found that CPM greatly inhibits cellular internalization of the complexes. Rott leads to a reduction of 46%, Wort to 31% and MbCD to 29%. These data further support the previous conclusions that the complexes appear to be internalized via different endocytic mechanisms, involving clathrin-dependent endocytosis, but also partially fluidphase pinocytosis and macropinocytosis. A more precise elucidation of the endocytic routes is beyond the scope of the current study, but we note that this could be done using cells in which proteins specific for endocytic routes are specifically knocked out (29).
Effect of Endorem-Lipofectamine complexes on cell viability.
In order to evaluate the effect of Endorem complexation with Lipofectamine on cell viability, HeLa cells were exposed to a wide range of particle concentrations (0, 25, 50, 100 and 200 µg Fe ml -1 ) complexed with various ratios of Lipofectamine (2.5, 5 and 10 µl ml -1 for 100 µg Fe ml -1 ). Figure 3 shows the cell viability data obtained after 24 h incubation measured by an lactate dehydrogenase (LDH) assay (Fig. 3a) and an MTT [(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay (Fig. 3b) . The data show that both assays lead to similar results, where any toxic effects are clearer in the MTT assay than in the corresponding LDH assay. This may be due to the fact that these assays assess cell viability by measuring different parameters, such as mitochondrial functionality and cell membrane permeability for the MTT 10 and LDH assay, respectively (34, 35) . The observed differences between these methods may therefore signify that the complexes do not appear to perturb cell membrane integrity, but rather affect mitochondrial functionality. For cells going into apoptosis, this will result in the translocation of cytoplasmic LDH into the extracellular medium.
The data show that free Lipofectamine at the concentrations used does not induce any cytotoxic effects, which is in accordance with the literature, where it has been reported that cytotoxic effects only occur when using concentrations above 10 µl ml -1 (9, 17) . When using small amounts of Lipofectamine (2.5 µl ml -1 for 100 µg Fe ml -1 ), none of the complexes appear to have any effect on cell viability up to 200 µg Fe ml -1 , which is in line with previous work (14, 15) . For medium Lipofectamine concentrations (5 µl ml -1 for 100 µg Fe ml -1 ), cell viability significantly decreased when incubated at the highest concentration of Endorem (200 µg Fe ml -1 ). For the highest Lipofectamine concentrations (10 µl ml -1 for 100 µg Fe ml -1 ), cell viability decreased in an Endorem concentration-dependent manner, significantly decreasing cell viability at amounts larger than 100 µg Fe ml -1 . Regarding the precise mechanism involved in the induction of cell death, it is interesting to note that high concentrations of Endorem (500 or 1000 µg Fe ml -1 ) with low amounts of Lipofectamine led to much higher cellular iron contents than the values obtained here, but did not induce any cytotoxic effects (9) . As the observed toxicity effects correlate with the occurrence of high amounts of cellassociated aggregates (Figs 1a and 2a) , it can probably be assumed that the substantial aggregation and cell surface covering by the complexes impair cell homeostasis, as has also been observed for various types of quantum dots (19).
Confocal analysis of complex internalization.
To complement the IONP cell adhesion and uptake studies by quantitative iron determination, confocal laser scanning microscopy was selected to further evaluate the precise intracellular localization of the particles and their uptake routes. To reduce the number of aggregates and as high intracellular iron contents might affect fluorescence-based analysis (9), HeLa cells were incubated with complexes at 25 µg Fe ml -1 (1.25 µl ml -1 Lipofectamine) for 4 h.
Following incubation with the various pharmacological endocytic inhibitors, the presence of Endorem was shown by immunostaining for dextran, followed by confocal analysis (Fig. 4) .
In all conditions, surface-associated complexes can be seen, surrounding the cell cytoplasm.
In line with the findings described above, treatment of the cells with Noco + Cyt D (Fig. 4e) or incubation at 4 °C (Fig. 4c) appeared to block nearly all endocytosis. When cells were incubated with Noco alone, some particles were found closer to the cell nucleus, but most remained close to the cell periphery (Fig. 4d) , which indicates the need of microtubules to transport the internalized particles from the cell periphery towards the perinuclear region. This is in line with common endocytic transport mechanisms where early endosomes move along the microtubules towards the late endosomes, which are located closer to the perinuclear region (36, 37) . In accordance to the data obtained for the cellular iron contents, the images show a clear reduction in internalized complexes for cells treated with CPM (Fig. 4i) or Rott (Fig. 4f) . Wort ( Fig. 4g) and MbCD (Fig. 4h ) led to only small effects which were hard to distinguish from control cells incubated at 37 °C. Interestingly, high levels of complexes were found associated with filopodial bridges between HeLa cells (Fig. 4c , bottom right corner), a finding which was also made by Ruan et al. (38) , who exposed HeLa cells to TAT-peptide conjugated quantum dots. These filopodia have also been described to be highly active in vesicle shedding and thereby lead to exocytosis of previously internalized particles (38) , which could also be the case for Endorem-Lipofectamine complexes.
Colocalization of Endorem complexes with endosomal markers.
Based on the data obtained earlier, the complexes appear to be internalized through clathrinmediated endocytosis, fluid-phase pinocytosis and macropinocytosis. As clathrin-mediated endocytosis is arguably the best characterized endocytic mechanism (39) and has been described to be involved in the internalization of different types of nanoparticles, including
IONPs (14, 40) , this finding correlates well with available literature data. Other, less common, endocytosis pathways, such as caveolin-or flotillin mediated endocytosis, may also participate in the uptake of the complexes and should therefore be looked into. Caveolae are flask-shaped membrane invaginations and are typically associated with cholesterol-rich membrane subdomains called lipid rafts; caveolin-mediated endocytosis is one of the main endocytic pathways for receptor-independent endocytosis. Flotillin-mediated endocytosis is a recently described endocytic uptake mechanism, typical for heparan sulfate proteoglycan receptors, and has been described as mediating the uptake of cationic macromolecules such as 12 polyethylenimine (41). The use of pharmacological endocytosis inhibitors, however, can sometimes be somewhat misleading as, for some of them, their effect can differ between cell types (29) . In addition, for several endocytic pathways, such as caveolin-or flotillin-mediated endocytosis, no good (noncytotoxic and 100% specific) pharmacological inhibitors are commonly available. In order to further unravel the mechanisms involved in the internalization of the complexes, the intracellular localization of internalized complexes was correlated with those of marker proteins, specific for distinctive endocytic processes (Fig. 5) .
By calculating the number of colocalized pixels for TA-IONP complexes and cellular markers, the degree of colocalization can be estimated (percentage of green pixels that colocalize with red pixels). Caveolin (9 + 2%)-or flotillin (13 + 3%)-mediated endocytosis do not appear to play a significant role ( Fig. 5a and b) , taking into account the very low levels of colocalization. The latter is somewhat surprising as the flotillin-mediated pathway has been described as involved in the internalization of cationic macromolecules after electrostatic interaction with cell surfacelocated heparan sulfate proteoglycans, which are negatively Based on these data, it appears that a large portion of the particles are internalized through fluid-phase pinocytosis, the pathway typically used for noncomplexed Endorem particles.
Non-complexed Endorem, however, is not attracted to the cell surface and is internalized rather inefficiently and with very slow kinetics, making it nearly impossible to include these particles in such short exposure conditions as no internalized IONPs can be seen within this short time span (7) . As a possible explanation of our results we propose the following hypothesis, which is summarized schematically in Scheme 2. Based on the net negative (Fig. 2f) .
Effect of internalized complexes on intracellular endosomes.
The findings above all point to an active endocytic uptake mechanism, which is in line with previous reports in which Endorem complexes have always been found in vesicular structures withinthe cell cytoplasm by means of electron microscopy (44), confirmed by the high levels of colocalization of the complexes and early endosomal antigen 1 (EEA1)-positive early endosomes at early time points (Fig. 6a) .
Interestingly, at early time points the cells show a clear punctuate staining pattern of the internalized complexes, indicative of endosomal localization. At later time points, this pattern changes dramatically and the complexes are primarily caught in a broad perinuclear ring-like structure, which also stains positive for lysosomal associated membrane protein 1 (Lamp-1; Fig. 6b ). From the transmission image (Fig. 6b4) , it can clearly be seen that the complexes seem to have concentrated or evenaggregated intracellularly as they can easily be picked up as optically dense structures. The Lamp-1 staining pattern, depicting lysosomes, is also substantially altered compared with the typical punctuate staining pattern in cells that were not exposed to IONPs (Fig. 6b5) . The lysosomes appear to have enlarged in size in order to be (46), impeded the functionality of PC12 cells (14) and affected the cytoskeleton of primary endothelial cells (9) , effects that have not been observed using pure Endorem particles.
The impact of nanoparticles on endocytic transport has already been touched upon by a few studies, where peptide-functionalized quantum dots were found not to undergo endocytic routing typically associated with the natural ligand the quantum dot was coupled with (47).
Intra-endosomal aggregation of IONPs has also been described (48) where endocytosed complexes have furthermore been found to affect the normal endocytic lifecycle, e.g. delaying the maturation of late endosomes into lysosomes (44) . Taken together, these data indicate that IONP complexes are internalized through typical endocytic pathways, after which they are mostly concentrated in the endolysosomes at later time points. Their intra-endosomal localization furthermore affects the morphology and the typical appearance of endosomes, possibly impeding the normal cellular functionality (45).
Conclusion
The present study shows that the addition of Lipofectamine to Endorem particles leads to the rapid formation of complexes that are quite stable in physiological saline, independent of the ratio of both components. For every condition, the main part of the surface of the Endorem particles remains free of Lipofectamine, resulting in a net negative surface charge in all conditions. The presence of serum greatly affects the stability of the complexes, where substantial aggregation occurs, the extent of which correlates with the amount of In light of cytotoxicity of the Endorem-Lipofectamine complexes, the substantial aggregation and cell surface covering by nanoparticles can drastically impair cell homeostasis (19) , a phenomenon that warrants the use of adequate safety precautions when employing transfection agents. The size of the aggregates will most likely depend on (a) the concentration of IONPs present, (b) the ratio of Lipofectamine over Endorem and (c) the presence of additional factors, such as serum proteins. This could be investigated further using fluorescence single particle tracking, a microscopy-based technique that was recently reported to be able to characterize nanoparticle aggregation in complex fluids (49) . Efficient IONP internalization, which is of primordial importance to allow for accurate MRI assessment of cell migration, can therefore probably be promoted more by reducing the amount of Lipofectamine, simply using solely free Endorem at higher concentrations, incubating the cells with the complexes in small amounts of serum or using other transfection agents that might not induce such heavy aggregation phenomena.
Materials and Methods
Cell culture.
HeLa cells were cultured in DMEM/F12 medium (Gibco, Invitrogen, Merelbeke, Belgium)
supplemented with 10% fetal calf serum, 1% penicillin-streptomycin and 2 mM L-Glutamine (Gibco, Invitrogen, Merelbeke, Belgium) in a humidified atmosphere with 5% CO 2 at 37 °C.
HeLa cells expressing a tetracycline-inducible dominant negative form of dynamin (HeLa dyn K44A) were maintained in the same medium, further containing 0.2 µg ml -1 puromycin, 0.4 mg ml -1 geneticin (Gibco, Invitrogen, Merelbeke, Belgium) and 1 µg ml -1 TET (SigmaAldrich, Bornem, Belgium). When HeLa dyn K44A cells were maintained in culture in the 16 presence of TET, only the natural form of dynamin was expressed, leading to fully functional cells. In order to induce expression of the mutant dynamin form, HeLa dyn K44A cells were given medium without any TET for 24 h prior to exposure of the cells to Endorem.
Endorem-Lipofectamine complexation for cell labeling.
For all magnetic cell labeling experiments, the various TA-IONP complexes were made in PBS, at concentrations of 1000 µg Fe ml -1 of Endorem and 25, 50 and 100 ml ml -1 Lipofectamine. These complexes were then slightly shaken at ambient temperature to allow complex formation, after which part of the stock solution was taken and diluted with complete cell medium to reach the required particle concentrations.
Dynamic light scattering and surface charge.
The hydrodynamic diameter and surface charge of the Endorem (Guerbet, Villepinte, 
DAB-enhanced Prussian blue staining of Endorem-treated HeLa cells.
HeLa cells were seeded in 12 well plates containing glass coverslips at 5*10 4 cells per well and allowed to settle overnight. Then, media were aspirated and fresh medium was given containing Endorem-Lipofectamine complexes (100 µg Fe ml -1 , 2.5, 5 or 10 µl ml 
Quantitative cellular iron determination.
Quantitative determination of cellular iron contents was carried out by a colorimetric assay using the disodium salt of 4,5-hydroxy-1,3-benzenedisulfonic acid (Tiron; Acros Organics, Geel, Belgium) as described previously (40 
Pharmacological endocytosis inhibitors.
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To study the uptake pathway of Endorem-Lipofectamine complexes in more detail, several confocal laser scanning microscope (Nikon Belux, Brussels, Belgium) and images processed with the Nikon EZ-C1 3.91 imaging software (Nikon Belux, Brussels, Belgium).
Confocal analysis of intracellular markers.
HeLa cells were seeded in 12 well plates containing glass coverslips at 5 was then analyzed for cell-internalized particles using ImageJ (NIH, USA) and the degree of colocalization was calculated using the colocalization analysis plugin, using 25 iterations and Fay randomization (MBF collection by Tony Collins).
Statistical analysis.
All data are expressed as mean + standard deviation unless indicated otherwise. To determine statistical significance of one group with respect to the control (iron uptake) data were analyzed using Student's t-test. In all cases, the degree of significance is indicated when appropriate (*p<0.05; **p<0.01; ***p<0.001). The images shown are merged images of the green and orange channels. In the bottom corner, 
